Last €16.38 EUR
Change Today +0.08 / 0.49%
Volume 0.0
SLS On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 2:09 AM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by JANUS CAPITAL GROUP INC (SLS) in the last 6 months

Announced 01/11/15
5.03B for NPS Pharmaceuticals, Inc.
Merger/Acquisition

Shire Pharmaceutical Holdings Ireland Limited signed an agreement to acquire NPS Pharmaceuticals, Inc. (NasdaqGS:NPSP) from shareholders for $4.9 billion in cash on January 11, 2015. The acquisition is structured as an all-cash tender offer for all of the outstanding shares of NPS Pharma at a price of $46 per share followed by a merger in which each remaining untendered share of NPS Pharma common stock would be converted into the same $46 cash per share consideration ...
Read More


SLS's price was unchanged after the transaction was announced on 01/11/15.
Investor / Buyer
Shire Pharmaceutical Holdings Ireland Limited
Creditor / Lender
Janus Capital Group, Inc.
Janus Global Life Sciences Fund
Financial Advisor
Goldman, Sachs & Co.
Leerink Partners LLC
Legal Advisor
Skadden, Arps, Slate, Meagher & Flom, L.L.P.
 
Announced 10/13/14
66.00M for VS Holdings Inc.
Merger/Acquisition

Janus Capital Group, Inc. (NYSE:JNS) agreed to acquire VS Holdings Inc. for $66 million on October 13, 2014. The transaction includes an initial upfront cash consideration of $30 million with up to an additional $36 million in contingent cash consideration if certain revenue targets are achieved over a four-year period. As part of the transaction, VelocityShares, LLC’s team will join Janus Capital Group. Closing of the transaction is subject to certain conditions, including ...
Read More


SLS's price was unchanged after the transaction was announced on 10/13/14.
Investor / Buyer
Janus Capital Group, Inc.
Financial Advisor
Freeman & Co.
Legal Advisor
Stoel Rives LLP
 
Announced 08/15/14
4.00M for Cosi Inc.
Private Placement

Cosi Inc. (NasdaqCM:COSI) announced a private placement of 3,889,613 common shares at $1.15 per share for gross proceeds of $4,473,055 on August 15, 2014. The company has signed the stock purchase agreement with a new accredited investor, Plaisance Fund LP, a fund managed by us Capital Group, Inc. An existing investor Milfam II, LP, a fund managed by Milfam LLC has a right to participate for 521,739 shares under its note purchase agreement with the company. In the event, ...
Read More


SLS's price was unchanged after the transaction was announced on 08/15/14.
Investor / Buyer
Janus Capital Group, Inc.
Milfam II, LP
Milfam LLC
Plaisance Fund LP
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SLS:GR €16.38 EUR +0.08

SLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SLS.
View Industry Companies
 

Industry Analysis

SLS

Industry Average

Valuation SLS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JANUS CAPITAL GROUP INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.